Carbon Dioxide Potentiates Flucytosine Susceptibility in Cryptococcus neoformans

Area of Science:

• Medical Mycology
• Antimicrobial Resistance
• Infectious Diseases

Background:

• Cryptococcal meningoencephalitis is a global health threat with limited treatment options.
• Flucytosine-based combination therapies are the most effective but require reliable susceptibility testing.
• Standard in vitro susceptibility testing may not accurately represent drug activity in the host environment.

Purpose of the Study:

• To investigate the impact of host-like carbon dioxide (CO2) concentrations on flucytosine susceptibility in clinical isolates of Cryptococcus neoformans.
• To elucidate the mechanism by which CO2 influences flucytosine activity, focusing on drug uptake pathways.

Main Methods:

• Clinical isolates of Cryptococcus neoformans were tested for flucytosine susceptibility under ambient and host-like CO2 conditions.
• Minimum Inhibitory Concentrations (MICs) were determined using standard Clinical and Laboratory Standards Institute (CLSI) methods.
• Gene expression analysis of the cytosine permease gene (FCY2) was performed in vitro and in a mouse lung infection model.

Main Results:

• Host-like CO2 concentrations significantly potentiated flucytosine susceptibility in 10 out of 11 clinical isolates.
• CO2 exposure increased flucytosine susceptibility in a dose-dependent manner (2- to 8-fold) compared to standard conditions.
• The gene encoding the cytosine permease (FCY2), responsible for flucytosine uptake, showed significantly induced expression (18- to 60-fold) in the mouse lung environment.

Conclusions:

• Flucytosine activity is highly dependent on the host environment, particularly CO2 levels, which influence drug uptake.
• Standard in vitro susceptibility testing may underestimate flucytosine efficacy due to the lack of host-like CO2 conditions.
• Accurate determination of flucytosine susceptibility requires culture conditions that mimic the host environment to ensure effective treatment of cryptococcal infections.